[1] |
李晓光,洪源,王琦, 等. B和C基因型乙型肝炎病毒对Huh7细胞全基因组表达模式的影响[J/CD]. 中华实验和临床感染病杂志(电子版),2012,6(6):520-526.
|
[2] |
贾海永. 新型杂环类乙肝病毒抑制剂的设计,合成及其活性研究[D]. 山东大学,2017.
|
[3] |
Galle PR, Hagelstein J, Kommerell B, et al. In vitro experimental infection of primary human hepatocytes with hepatitis B virus[J]. Gastroenterology,1994,106(3):664-673.
|
[4] |
Katsura N, Ikai I, Mitaka T, et al. Long-term culture of primary human hepatocytes with preservation of proliferative capacity and differentiated functions[J]. J Surg Res,2002,106(1):115-123.
|
[5] |
Schulzebergkamen H, Untergasser A, Dax A, et al. Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection[J]. J Hepatol,2003,38(6):736-744.
|
[6] |
甘建,杨睿,雷程程, 等. 体外HBV感染的人肝癌Huh7细胞系中葡萄糖神经酰胺合成酶活性的变化[J]. 临床肝胆病杂志,2021,37(4):829-833.
|
[7] |
胡平平,李军,朱传龙. 乙型肝炎病毒体外培养细胞模型研究进展[J]. 肝脏,2017,22(9):841-844.
|
[8] |
Yan RQ, Su JJ, Huang DR, et al. Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus[J]. Cancer Res Clin,1996,122(5):283-288.
|
[9] |
Gripon P, Diot C, Thézé N, et al. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide[J]. Virol,1988,62(11):4136-4143.
|
[10] |
Leite SB. Three-dimensional hepaRG model as an attractive tool for toxicity testing[J]. Toxicol Sci,2012,130(1):106-116.
|
[11] |
Malinen MM, Palokangas H, Yliperttula M, et al. Peptide nanofiber hydrogel induces formation of bile canaliculi structures in three-dimensional hepatic cell culture[J]. Tissue Eng Pt A,2012,18(23-24): 2418.
|
[12] |
Zhou M, Zhao F, Li J, et al. Long-term maintenance of human fetal hepatocytes and prolonged susceptibility to HBV infection by co-culture with non-parenchymal cells[J]. J Virol Methods,2014,195(1):185-193.
|
[13] |
Bchini R, Capel F, Dauguet C, et al. In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus[J]. J Virol,1990,64(6):3025-3032.
|
[14] |
Mabit H, Dubanchet S, Capel F, et al. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences[J]. J Gen Virol,1994,75(Pt 10):2681-2689.
|
[15] |
Gripon P, Rumin S, Urban S, et al. Infection of a human hepatoma cell line by hepatitis B virus[J]. Proc Natl Acad Sci USA,2002,99(24):15655-15660.
|
[16] |
Marion MJ, Hantz O, Durantel DT, et al. The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies[J]. Methods Mol Biol,2010,640:261-272.
|
[17] |
杨炜峰,苗振川,宋希军, 等. HBV感染的动物模型研究进展[J]. 临床肝胆病杂志,2021,37(5):999-1005.
|
[18] |
Alexander J, Bey E, Whitcutt JM, et al. Adaptation of cells derived from human malignant tumours to growth in vitro[J]. S Afr J Med Sci,1976,41(2):89-98.
|
[19] |
毕延伟,杨小强,孙平楠, 等. HBV研究模型新进展[J]. 癌变·畸变·突变,2019,31(2):166-170.
|
[20] |
Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA[J]. Proc Natl Acad Sci USA,1987,84(4):1005-1009.
|
[21] |
韩建,王晓娟,刘鹏, 等. HepG2.2.15细胞模型功能的重新评价:分泌HBVDNA、cccDNA及血清学标志物的动态变化研究[J]. 中国病原生物学杂志,2013,8(5):385-388.
|
[22] |
刘茂昌,王贵强,朴文花, 等. HBV cccDNA在2.2.15细胞表达的动态观察[J]. 中华实验和临床病毒学杂志,2005,19(4):391-394.
|
[23] |
Ladner SK, Otto MJ, Barker CS, et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: A novel system for screening potential inhibitors of HBV replication[J]. Antimicrob Agents Ch,1997,41(8):1715-1720.
|
[24] |
Ladner SK, Otto MJ, Barker CS, et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication[J]. Antimicrob Agents Chemother,1997,41(8):1715-1720.
|
[25] |
徐桂利,高新,刘铮铸, 等. 乙肝病毒体内外感染模型研究进展[J]. 中国比较医学杂志,2016,26(9):93-98.
|
[26] |
Levrero M, Pollicino T, Petersen J, et al. Control of cccDNA function in hepatitis B virus infection[J]. J Hepatol,2009,51(3):581-592.
|
[27] |
Cai DW, Mills C, Yu WQ, et al. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation[J]. Antimicrob Agents Ch,2012,56(8):4277-4288.
|
[28] |
Delaney WT, Miller T, Hc. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2' 3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA Antimicrob Agents[J]. Antimicrob Agents Chemother,1999,43(8):2017-2026.
|
[29] |
周彬,梁敏锋,李伟东, 等. 应用腺病毒载体系统将HBV/C全基因组转导入HepG2细胞的方法学研究[J]. 南方医科大学学报,2008,28(10):1764-1767.
|
[30] |
Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus[J]. Elife,2012,1:e00049.
|
[31] |
Yan R, Zhang Y, Cai D, et al. Spinoculation enhances HBV infection in NTCP-reconstituted hepatocytes[J]. PLoS One, 2015,10(6):e0129889.
|
[32] |
潘孝本,朱琳,高燕, 等. QSG-7701和HepG2细胞支持不同乙型肝炎病毒复制模式及其机制[J]. 中华肝脏病杂志,2007,15(2):83-87.
|
[33] |
Zhang L, Zhang W, Shao C, et al. Establishment and characterization of a spontaneously immortalized trophoblast cell line (HPT-8) and its hepatitis B virus-expressing clone[J]. Hum Reprod,2011,26(8):2146-2156.
|
[34] |
Wang RY, Shen CN, Lin MH, et al. Hepatocyte-like cells transdifferentiated from a pancreatic origin can support replication of hepatitis B virus[J]. J Virol,2005,79(20):13116-13128.
|